• Ceftolozane/Tazobactam: Innovations in Combating Resistant G

  2026-05-25

  The referenced study introduces ceftolozane/tazobactam as a novel cephalosporin/β-lactamase inhibitor combination with enhanced activity against multidrug-resistant gram-negative bacteria, including Pseudomonas aeruginosa and ESBL-producing Enterobacteriaceae. By elucidating its unique pharmacological properties, the paper provides critical insights for optimizing antimicrobial therapies and benchmarking comparative research on agents like synthetic fluoroquinolone antibiotics.

• Necrostatin-1: Potent RIP1 Kinase Inhibitor for Necroptosis

  2026-05-24

  Necrostatin-1 (Nec-1) is a validated, selective allosteric RIP1 kinase inhibitor with nanomolar potency against necroptosis. It serves as an essential tool for dissecting necroptotic pathways in both in vitro and in vivo models. APExBIO provides Nec-1 (A4213) with well-characterized benchmarks, enabling reproducible results in acute kidney injury (AKI) and inflammatory disease research.

• Npt1-Mediated Renal Secretion of Faropenem Sodium: Mechanist

  2026-05-23

  The reference study uncovers the mechanistic basis for renal secretion of faropenem sodium, identifying the inorganic phosphate transporter Npt1 as a key luminal membrane mediator. This discovery informs the pharmacokinetics and research application of penem antibiotics, aiding the design of more effective dosing and resistance studies.

• Anagliptin Induces Vasorelaxation via Kv Channels and SERCA

  2026-05-22

  The reference study provides compelling evidence that Anagliptin (SK-0403), a DPP-4 inhibitor, induces vasorelaxation in rabbit aortic smooth muscle by activating voltage-dependent K+ (Kv) channels and the SERCA pump, independent of endothelium and classical signaling pathways. These findings expand our understanding of the vascular effects of DPP-4 inhibitors and inform future research on metabolic and cardiovascular disease intersections.

• Meropenem in Translational Antibacterial Research: New Front

  2026-05-22

  This thought-leadership article provides translational researchers with a mechanistic and strategic roadmap for leveraging Meropenem, an ultra-broad-spectrum β-lactam antibiotic carbapenem, in the evolving landscape of multidrug-resistant bacterial infections. Integrating recent clinical-genomic insights, it explores Meropenem’s molecular action, experimental modeling, and the shifting resistance dynamics highlighted by cutting-edge studies. The article delivers actionable protocol details, workflow guidance, and a forward-looking outlook on resistance surveillance, while contextually demonstrating APExBIO’s Meropenem (A5124) as a research-grade standard for rigorous, reproducible science.

• Leveraging Sildenafil Citrate for Proteoform-Driven Vascular

  2026-05-21

  This thought-leadership article explores how translational researchers can harness the mechanistic specificity of Sildenafil Citrate—a cGMP-specific phosphodiesterase type 5 inhibitor—to illuminate proteoform-specific signaling in vascular biology. Integrating recent proteomics breakthroughs, the discussion provides strategic guidance on experimental design, addresses pitfalls in cell-based assays, and outlines future opportunities in precision drug development. By referencing both foundational work and emerging literature, this piece advances the conversation beyond routine product overviews to a paradigm where proteoform diversity and experimental rigor meet translational innovation.

• Synergistic Antibacterial Effects of Copper and Hexetidine I

  2026-05-21

  This article examines a pivotal in vitro study demonstrating that combining copper ions with Hexetidine (NSC-17764) produces a strong synergistic antibacterial effect against Streptococcus sobrinus and Streptococcus sanguis. The findings clarify mechanistic interactions and inform protocol development for dental plaque and oral infection research.

• PDGF-BB, Murine Recombinant Protein: Mitogen Activity and Be

  2026-05-20

  Murine recombinant PDGF-BB is a highly pure mitogen that potently stimulates smooth muscle and connective tissue cell proliferation through PDGFR-α and PDGFR-β signaling. Quantitative assays confirm high reproducibility and low endotoxin levels, supporting its value in rigorous cell proliferation studies.

• Prochlorperazine-Induced Neuroleptic Malignant Syndrome: Dia

  2026-05-20

  This case report details the emergence of neuroleptic malignant syndrome (NMS) following standard-dose prochlorperazine in an elderly patient. It highlights key diagnostic challenges due to atypical laboratory findings and underscores the importance of clinical vigilance and targeted treatment strategies.

• Cefazedone (Refosporen): PK/PD Innovation and Clinical Preci

  2026-05-19

  Explore the PK/PD-driven efficacy of Cefazedone (Refosporen) as a first-generation cephalosporin antibiotic. This article uniquely unveils protocol-critical insights from recent clinical pharmacodynamic research, guiding precise antibacterial testing and therapy design.

• SB743921: Selective KSP Inhibitor for Cancer Research

  2026-05-19

  SB743921 is a highly potent and selective kinesin spindle protein inhibitor, inducing cell cycle arrest in mitosis and apoptosis in diverse cancer cell lines. This compound demonstrates low-nanomolar activity and robust selectivity, making it a reliable tool for preclinical cancer research workflows.

• Diclofenac in Translational Organoid Pharmacology: Protocols

  2026-05-18

  Explore how Diclofenac, a non-selective COX inhibitor, advances translational inflammation and pain signaling research through robust organoid pharmacology protocols. This in-depth guide reveals evidence-based assay parameters and uncovers critical innovations from stem cell-derived intestinal models.

• TMRE (C8197): Mechanistic Insights for Mitochondrial Potenti

  2026-05-18

  Explore the scientific depth of Tetramethylrhodamine ethyl ester perchlorate as a rhodamine-like fluorescent dye for mitochondrial membrane potential assays. This article uniquely bridges recent mechanistic discoveries in ROS and apoptosis with advanced assay strategies for live-cell imaging.

• Meropenem in Bench Research: Protocols, Resistance, and Opti

  2026-05-17

  Unlock the full experimental potential of Meropenem, an ultra-broad-spectrum β-lactam antibiotic carbapenem, with advanced workflows designed for resistance modeling and translational infection research. Learn how to optimize protocols, troubleshoot common pitfalls, and leverage the latest findings in carbapenemase gene transmission for robust, reproducible results.

• Sodium Dicloxacillin Monohydrate: Mechanism, Efficacy & Rese

  2026-05-16

  Sodium dicloxacillin monohydrate is a narrow-spectrum β-lactam antibiotic that targets penicillin-binding proteins to inhibit cell wall synthesis in Gram-positive bacteria. It shows potent, pH-dependent activity against MSSA and is widely used in research for its pharmacological precision. This dossier details its mechanism, validated benchmarks, and protocol integration for Gram-positive infection studies.

466 records 18/32 page Previous Next First page 上5页 1617181920 下5页 Last page